Control Bionics Overview

  • Status
  • Public

  • Employees
  • 41

Employees

  • Stock Symbol
  • CBL

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $0.03
  • (As of Friday Closing)

Control Bionics General Information

Description

Control Bionics Ltd is a neurotechnology company commercialising objective, non-invasive neural-signal technology in clinical environments, built to scale across multiple markets. Its neural-signal platform captures physiological signals, including the electrical activity generated by muscles, with medical-grade precision, converting them into measurable, decision-ready outcomes. Its products include NeuroNode, NeuroStrip, NeuroNode Trilogy Systems, NeuroNode Duo, EyeGaze Duo, and others. Geographically, it derives a majority of its revenue from North America, with a presence in Australia, Japan, and other markets.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Corporate Office
  • Level 4, 11-13
  • Pearson Street
  • Cremorne, Victoria 3121
  • Australia
+61 (03)
Primary Industry
Therapeutic Devices
Other Industries
Monitoring Equipment
Stock Exchange
ASX
Corporate Office
  • Level 4, 11-13
  • Pearson Street
  • Cremorne, Victoria 3121
  • Australia
+61 (03)

Control Bionics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Control Bionics Stock Performance

As of 20-Nov-2026, Control Bionics’s stock price is $0.03. Its current market cap is $15.3M with 544M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.03 $0.03 $0.03 - $0.07 $15.3M 544M 438K

Control Bionics Financials Summary

As of 30-Sep-2026, Control Bionics has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 30-Sep-2026 FY 2026 30-Jun-2026 FY 2025 30-Jun-2025 FY 2024 30-Jun-2024
EV 22,512 19,040 5,434 6,070
Revenue 3,292 3,864 3,360
EBITDA (4,332) (3,267) (3,294)
Net Income (4,922) (3,952) (3,876)
Total Assets 6,226 5,378 6,034
Total Debt 426 284 643
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Control Bionics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Control Bionics‘s full profile, request access.

Request a free trial

Control Bionics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Control Bionics Ltd is a neurotechnology company commercialising objective, non-invasive neural-signal technology in cli
Therapeutic Devices
Cremorne, Australia
41 As of 2024

Sydney, Australia
 

Warwick, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Control Bionics Competitors (2)

One of Control Bionics’s 2 competitors is Liberator, a Corporation company based in Sydney, Australia.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Liberator Corporation Sydney, Australia
Tobii Dynavox Limited Corporation Warwick, United Kingdom
You’re viewing 2 of 2 competitors. Get the full list »

Control Bionics Patents

Control Bionics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026090276-A1 Switch control system for assistive devices Pending 23-Oct-2024
WO-2025250868-A1 Method for monitoring and collecting physiological data using a flexible patch device Pending 30-May-2024
AU-2024353925-A1 Artificial intelligence-based system and method for creating digital arts and stories Pending 26-Sep-2023
EP-4785124-A1 Artificial intelligence-based system and method for creating digital arts and stories Pending 26-Sep-2023
WO-2025072442-A1 Artificial intelligence-based system and method for creating digital arts and stories Inactive 26-Sep-2023 G06F3/0482
To view Control Bionics’s complete patent history, request access »

Control Bionics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Control Bionics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Control Bionics‘s full profile, request access.

Request a free trial

Control Bionics Investments (1)

Control Bionics’s most recent deal was a Corporate with Neuro Elite Athletics for . The deal was made on 16-Dec-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Neuro Elite Athletics 16-Dec-2024 Corporate Other Services (B2C Non-Financial)
To view Control Bionics’s complete investments history, request access »

Control Bionics ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Software & Services

Industry

Rank

Percentile

Enterprise and Infrastructure Software

Subindustry

Rank

Percentile

To view Control Bionics’s complete esg history, request access »

Control Bionics FAQs

  • Where is Control Bionics headquartered?

    Control Bionics is headquartered in Cremorne, Australia.

  • What is the size of Control Bionics?

    Control Bionics has 41 total employees.

  • What industry is Control Bionics in?

    Control Bionics’s primary industry is Therapeutic Devices.

  • Is Control Bionics a private or public company?

    Control Bionics is a Public company.

  • What is Control Bionics’s stock symbol?

    The ticker symbol for Control Bionics is CBL.

  • What is the current stock price of Control Bionics?

    As of 20-Nov-2026 the stock price of Control Bionics is $0.03.

  • What is the current market cap of Control Bionics?

    The current market capitalization of Control Bionics is $15.3M.

  • Who are Control Bionics’s competitors?

    Liberator and Tobii Dynavox Limited are competitors of Control Bionics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process